Magnesium neuroprotection is limited in humans with acute brain injury

Neurocritical Care

Volumn 2, Issue 3, 2005, Pages 342-351

  McKee, J Andrew ^a   Brewer, Randall P ^a   Macy, Gary E ^a   Borel, Cecil O ^a   Reynolds, James D ^a   Warner, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain ischemia; Cerebrospinal fluid; Magnesium sulfate; Neuroprotective agents; Subarachnoid hemorrhage; Traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICARDIPINE;

BLOOD BRAIN BARRIER; BOLUS INJECTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN VASOSPASM; CELL ENERGY; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CHOROID PLEXUS; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ECLAMPSIA; EXPERIMENTAL MODEL; GLASGOW OUTCOME SCALE; HUMAN; HYPERMAGNESEMIA; MAGNESIUM DEFICIENCY; MAGNESIUM DEPLETION; MAGNESIUM METABOLISM; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; STROKE; SUBARACHNOID HEMORRHAGE;

BRAIN INJURIES; BRAIN ISCHEMIA; ECLAMPSIA; FEMALE; HOMEOSTASIS; HUMANS; MAGNESIUM; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; PREGNANCY; SUBARACHNOID HEMORRHAGE;

EID: 23444450568     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:2:3:342     Document Type: Review

References (62)

1. Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnesium Res 1998;11:43-56.
2. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien) 2003;145:195-199.
3. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002;96:510-514.
4. Muir KW, Lees KR. Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke 1998;29:918-923.
5. Investigators IMAGES. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke Trial): randomized controlled trial. Lancet 2004;363:439-445.
6. Saver JL KC, Lear MC. Results of the Field Administration of Stroke Treatment-Magnesium (FAST-MAG) pilot trial: a study of prehospital neuroprotective therapy. Stroke 2002;33:353.
7. Oppelt WW, MacIntyre I, Rall DP. Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 1963;205:959-962.
8. Elin R. Magnesium metabolism in health and disease. Dis Mon 1988;34:165-218.
9. Neuwelt EA, Abbott NJ, Drewes L, et al. Cerebrovascular biology and the various neural barriers: challenges and future directions. Neurosurgery 1999;44:604-608.
10. Pollay M. Transport mechanisms in the choroid plexus. Fed Proc 1974;44:2064-2069.
11. Chutkow JG. Metabolism of magnesium in the central nervous system. Neurology 1974;24:780-787.
12. Hallak M, Berman RF, Irtenkauf SM, Evans MI, Cotton DB. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am J Obstet Gynecol 1992;167:1605-1610.
13. Heath DL, Vink R. Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J Pharmacol Exp Ther 1999;288:1311-1316.
14. Feldman Z, Gurevitch B, Artru AA, et al. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg 1996;85:131-137.
15. Altura BT, Memon ZI, Zhang A, et al. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells. Neurosci Lett 1997; 230:37-40.
16. Memon ZI AB, Benjamin JL, Cracco RQ, Altura BM. Predictive value of serum ionized but not total magnesium levels in head injuries. Scand J Clin Lab Invest 1995;55:671-677.
17. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003;52:276-281.
18. Miura K. Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++ - effects on the contractions of bovine cerebral artery. Neurol Med Chir (Tokyo) 1988;16:1251-1259.
19. Kahraman SO, T. Kayali, H. Atabey, C. Kutluay, T. Timurkaynak, E. Monitoring of serum ionized magnesium in neurosurgical intensive care unit: preliminary results. Clin Chim Acta 2003;334:211-215.
20. Polderman KH, van Zanten AR, Girbes AR. The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms. Intensive Care Med 2003;29:1202-1203.
21. Lampl Y, Geva, D, Dilad, R, Eshel, Y, Ronen, L, Sarova-Pinhas I. Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke. J Neurol 1998;245:584-588.
22. Amighi J, Sabeti S, Schlager O, et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 2004;35:22-27.
23. Lin JY, Chung SY, Lin MC, Cheng FC. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Sci 2002;71:803-811.
24. Heath DL, Vink R. Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: a comparative phosphorus NMR study. J Neurotraum 1998;15:183-189.
25. Schanne FA, Gupta RK, Stanton PK. 31P-NMR study of transient ischemia in rat hippocampal slices in vitro. Biochim Biophys Acta 1993;1158:257-263.
26. Hoffman DJ, Marro PJ, McGowan JE, Mishra OP, Delivoria-Papadopoulos M. Protective effect of MgSO4 infusion on NMDA receptor binding characteristics during cerebral cortical hypoxia in the newborn piglet. Brain Res 1994;644:144-149.
27. Vink R OCC, Nimmo AJ, Heath DL. Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats. Neurosci Lett 2003;336:441-444.
28. McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res 1989;482:252-260.
29. Tsuda T, Kogure K, Nishioka K, Watanabe T. Mg2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the Ca1 neurons in the rat hippocampus. Neuroscience 1991;44:335-341.
30. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991;22:922-927.
31. Pyne GJ, Cadoux-Hudson TA, Clark JF. Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg 2001;15:409-415.
32. Kemp P, Gardiner SM, Bennett T, Rubin PC. Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-1, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-arginine methyl ester, in conscious rats. Clin Sci 1993;85:175-181.
33. Huang QF, Gebrewold A, Zhang A, Altura BT, Altura BM. Role of excitatory amino acids in regulation of rat pial microvasculature. Am J Physiol 1994;266:R158-163.
34. van den Bergh WM, Zuur JK, Kamerling NA, et al. Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg 2002;97:416-422.
35. Chi OZ, Pollak P, Weiss HR. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 1990;304:196-205.
36. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991;11:1025-1030.
37. Yang Y, Li Q, Ahmad F, Shuaib A. Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. Neurosci Lett 2000;285:119-122.
38. Saver JL KC, Eckstein M, Starkman S; FAST-MAG Pilot Trial Investigators. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy (FAST-MAG) pilot trial. Stroke 2004;35:e106-e108.
39. Zhu HD MR, Meloni B, Oltvolgyi C, Moore S, Majda B. Magnesium sulfate fails to reduce infarct volume following transient focal ischemia in rats. Neurosci Res 2004;49:347-353.
40. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996;85:117-124.
41. Greene MF. Magnesium sulfate for preeclampsia. N Engl J Med 2003;348:275-276.
42. Lucas MJ, Leveno KJ, Cunningham, FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-205.
43. Belfort MA, Anthony J, Saade GR, Allen JC Jr., Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003;348:304-311.
44. Belfort MA, Moise KJ Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992;167:661-666.
45. Muir KW, Lees KR. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke 1995;26:1183-1188.
46. Lampl Y, Gilad R, Geva D, Eshel Y, Sadeh M. Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. Clin Neuropharmacol 2001;24:11-15.
47. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000;47:602-606.
48. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO. Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol 2001;13:202-206.
49. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium Sulfate in aneurysmal subarachnoid hemorrhage: a randomized trial. Stroke 2005;36:1011-1015.
50. Canavero S BV, Narcisi P. Safety of magnesium-lidocaine combination for severe head injury: the Turin liodomag pilot study. Surg Neurol 2003;60:165-169.
51. Choi WW, Warner DS, Monahan DJ, Todd MM. Effects of acute hypermagnesemia on the threshold for lidocaine-induced seizures in the rat. Am J Obstet Gynecol 1991;164: 693-697.
52. Cohen H The magnesium content of the cerebro-spinal fluid and other body fluids. Q J Med 1927;20:173-186.
53. Somjen G, Hilmy M, Stephen CR. Failure to anesthetize human subjects by intravenous administration of magnesium sulfate. J Pharmacol Exp Ther 1966;154:652-659.
54. Ko SH, Lim HR, Kim DC, Han YJ, Choe H, Song HS. Magnesium sulfate does not reduce postoperative analgesic requirements. Anesthesiology 2001;95:640-646.
55. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987;157:1435-1438.
56. Fuchs-Buder T, Tramer MR, Tassonyi E. Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol 1997;9:324-328.
57. Brewer RP, Parra A, Borel CO, Hopkins MB, Reynolds JD. Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension. Clin Neuropharmacol 2001;24:341-345.
58. McKee JA, Brewer RP, Macy GE, et al. Analysis of the brain bioavailability of peripherally administered MgSO4: a study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med 2005;33:661-666.
59. Germano A, d'Avella D, Cicciarello R, Hayes RL, Tomasello F. Blood-brain barrier permeability changes after experimental subarachnoid hemorrhage. Neurosurgery 1992;30:882-886.
60. Albayrak S, Zhao Q, Siesjo BK, Smith ML. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury. Acta Neuropathol (Berl) 1997;94: 158-163.
61. Menzies SA, Hoff JT, Betz AL. Extravasation of albumin in ischaemic brain oedema. Acta Neurochir (Wien) 1990;51:220-222.
62. Sickmann A. Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 2000;21:2721-2728.